Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Ulimorelin in Diabetic Gastroparesis
NCT00889486Phase 2Completed
- Sponsor
- Tranzyme Pharma
- Start
- Apr 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 6
01
Overview
A Phase 2 trial of ulimorelin in diabetic gastroparesis, sponsored by Tranzyme Pharma. Started Apr 2009; status: completed.
02
Drugs
ulimorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT00889486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889486.